Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1991 Jan;65(1):23–30. doi: 10.1128/jvi.65.1.23-30.1991

Sequences from myeloblastosis-associated virus MAV-2(O) and UR2AV involved in the formation of plaques and the induction of osteopetrosis, anemia, and ataxia.

R E Aurigemma 1, J L Torgersen 1, R E Smith 1
PMCID: PMC240485  PMID: 1845886

Abstract

Recombinant viruses were made between myeloblastosis-associated virus MAV-2(O) and UR2AV to examine the relationship between regions of the MAV-2(O) genome and disease induction. The env-long terminal repeat (LTR) portion of MAV-2(O), when substituted into UR2AV, was sufficient to induce osteopetrosis identical to that caused by the parent MAV-2(O). When this region was reduced to the gp37 and LTR of MAV-2(O), osteopetrosis more severe than that caused by the parent virus was induced. Recombinant viruses that contained all or part of the MAV-2(O) env gene in the absence of the MAV-2(O) LTR induced a severe, chronic anemia and late-onset osteopetrosis, leading to the conclusion that the MAV-2(O) LTR, in addition to env, was required for rapid induction of osteopetrosis. A viral recombinant, pEU, which contained the gp85 segment of UR2AV substituted into MAV-2(O), induced an ataxia/cerebellar dysfunction not seen during infection with the other chimeric or parent viruses. In vitro studies of the parent and recombinant viruses demonstrated that the ability to form plaques on chicken embryo fibroblasts correlated with the presence of the MAV-2(O) gp37 and LTR except for construct pEU. When the viruses were inoculated into 10-day-old chickens, chimeras containing the env-LTR of gp37-LTR region of MAV-2(O) induced severe regenerative anemia similar to that induced by MAV-2(O). pEU was the exception, suggesting that the unique configuration of this chimera is responsible for its unusual pathogenic properties.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurigemma R. E., Comstock R. D., Smith R. E. Persistent viral DNA synthesis associated with an avian osteopetrosis-inducing virus. Virology. 1989 Aug;171(2):626–629. doi: 10.1016/0042-6822(89)90636-3. [DOI] [PubMed] [Google Scholar]
  2. Aurigemma R. E., Simon M. C., Hayward W. S., Smith R. E. Preparation of a detailed restriction map of the avian leukosis virus MAV-2(O). Avian Dis. 1990 Jan-Mar;34(1):99–105. [PubMed] [Google Scholar]
  3. BEARD J. W. VIRAL TUMORS OF CHICKENS WITH PARTICULAR REFERENCE TO THE LEUKOSIS COMPLEX. Ann N Y Acad Sci. 1963 Nov 4;108:1057–1085. doi: 10.1111/j.1749-6632.1963.tb13436.x. [DOI] [PubMed] [Google Scholar]
  4. Banes A. J., Smith R. E. Biological characterization of avian osteopetrosis. Infect Immun. 1977 Jun;16(3):876–884. doi: 10.1128/iai.16.3.876-884.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beard J. W., Chabot J. F., Beard D., Heine U., Houts G. E. Renal neoplastic response to leukosis virus strains BAI A (avian myeloblastosis virus) and MC29. Cancer Res. 1976 Feb;36(2 Pt 1):339–353. [PubMed] [Google Scholar]
  6. Bosch M. L., Earl P. L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science. 1989 May 12;244(4905):694–697. doi: 10.1126/science.2541505. [DOI] [PubMed] [Google Scholar]
  7. Carter J. K., Ow C. L., Smith R. E. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun. 1983 Jan;39(1):410–422. doi: 10.1128/iai.39.1.410-422.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cheng-Mayer C., Rutka J. T., Rosenblum M. L., McHugh T., Stites D. P., Levy J. A. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A. 1987 May;84(10):3526–3530. doi: 10.1073/pnas.84.10.3526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cummins T. J., Orme I. M., Smith R. E. Reduced in vivo nonspecific resistance to Listeria monocytogenes infection during avian retrovirus-induced immunosuppression. Avian Dis. 1988 Oct-Dec;32(4):663–667. [PubMed] [Google Scholar]
  10. Cummins T. J., Smith R. E. Analysis of hematopoietic and lymphopoietic tissue during a regenerative aplastic crisis induced by avian retrovirus MAV-2(O). Virology. 1988 Apr;163(2):452–461. doi: 10.1016/0042-6822(88)90286-3. [DOI] [PubMed] [Google Scholar]
  11. Dorner A. J., Coffin J. M. Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85. Cell. 1986 May 9;45(3):365–374. doi: 10.1016/0092-8674(86)90322-3. [DOI] [PubMed] [Google Scholar]
  12. Dorner A. J., Stoye J. P., Coffin J. M. Molecular basis of host range variation in avian retroviruses. J Virol. 1985 Jan;53(1):32–39. doi: 10.1128/jvi.53.1.32-39.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eilbott D. J., Peress N., Burger H., LaNeve D., Orenstein J., Gendelman H. E., Seidman R., Weiser B. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc Natl Acad Sci U S A. 1989 May;86(9):3337–3341. doi: 10.1073/pnas.86.9.3337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ewert D. L., Steiner I., DuHadaway J. In ovo infection with the avian retrovirus RAV-1 leads to persistent infection of the central nervous system. Lab Invest. 1990 Feb;62(2):156–162. [PubMed] [Google Scholar]
  15. Gallaher W. R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 1987 Jul 31;50(3):327–328. doi: 10.1016/0092-8674(87)90485-5. [DOI] [PubMed] [Google Scholar]
  16. Graf T. A plaque assay for avian RNA tumor viruses. Virology. 1972 Nov;50(2):567–578. doi: 10.1016/0042-6822(72)90408-4. [DOI] [PubMed] [Google Scholar]
  17. Graf T., Beug H. Avian leukemia viruses: interaction with their target cells in vivo and in vitro. Biochim Biophys Acta. 1978 Nov 17;516(3):269–299. doi: 10.1016/0304-419x(78)90011-2. [DOI] [PubMed] [Google Scholar]
  18. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 1987 Sep 11;237(4820):1351–1355. doi: 10.1126/science.3629244. [DOI] [PubMed] [Google Scholar]
  19. Neckameyer W. S., Wang L. H. Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses. J Virol. 1984 Jun;50(3):914–921. doi: 10.1128/jvi.50.3.914-921.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Paterson R. W., Smith R. E. Characterization of anemia induced by avian osteopetrosis virus. Infect Immun. 1978 Dec;22(3):891–900. doi: 10.1128/iai.22.3.891-900.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Price J. A., Smith R. E. Inhibition of concanavalin A response during osteopetrosis virus infection. Cancer Res. 1982 Sep;42(9):3617–3624. [PubMed] [Google Scholar]
  22. Resnick-Roguel N., Burstein H., Hamburger J., Panet A., Eldor A., Vlodavsky I., Kotler M. Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol. 1989 Oct;63(10):4325–4330. doi: 10.1128/jvi.63.10.4325-4330.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robinson H. L., Blais B. M., Tsichlis P. N., Coffin J. M. At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1225–1229. doi: 10.1073/pnas.79.4.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Robinson H. L., Jensen L., Coffin J. M. Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1. J Virol. 1985 Sep;55(3):752–759. doi: 10.1128/jvi.55.3.752-759.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Robinson H. L., Reinsch S. S., Shank P. R. Sequences near the 5' long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis. J Virol. 1986 Jul;59(1):45–49. doi: 10.1128/jvi.59.1.45-49.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shank P. R., Schatz P. J., Jensen L. M., Tsichlis P. N., Coffin J. M., Robinson H. L. Sequences in the gag-pol-5'env region of avian leukosis viruses confer the ability to induce osteopetrosis. Virology. 1985 Aug;145(1):94–104. doi: 10.1016/0042-6822(85)90204-1. [DOI] [PubMed] [Google Scholar]
  27. Simon M. C., Neckameyer W. S., Hayward W. S., Smith R. E. Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus. J Virol. 1987 Apr;61(4):1203–1212. doi: 10.1128/jvi.61.4.1203-1212.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Simon M. C., Smith R. E., Hayward W. S. Mechanisms of oncogenesis by subgroup F avian leukosis viruses. J Virol. 1984 Oct;52(1):1–8. doi: 10.1128/jvi.52.1.1-8.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith R. E. Avian osteopetrosis. Curr Top Microbiol Immunol. 1982;101:75–94. doi: 10.1007/978-3-642-68654-2_4. [DOI] [PubMed] [Google Scholar]
  30. Smith R. E., Bernstein E. H. Production and purification of large amounts of Rous sarcoma virus. Appl Microbiol. 1973 Mar;25(3):346–353. doi: 10.1128/am.25.3.346-353.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith R. E., Moscovici C. The oncogenic effects of nontransforming viruses from avian myeloblastosis virus. Cancer Res. 1969 Jul;29(7):1356–1366. [PubMed] [Google Scholar]
  32. Smith R. E., Van Eldik L. J. Characterization of the immunosuppression accompanying virus-induced avian osteopetrosis. Infect Immun. 1978 Nov;22(2):452–461. doi: 10.1128/iai.22.2.452-461.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stoler M. H., Eskin T. A., Benn S., Angerer R. C., Angerer L. M. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA. 1986 Nov 7;256(17):2360–2364. [PubMed] [Google Scholar]
  34. Vieira J., Messing J. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene. 1982 Oct;19(3):259–268. doi: 10.1016/0378-1119(82)90015-4. [DOI] [PubMed] [Google Scholar]
  35. Wang L. H., Duesberg P., Beemon K., Vogt P. K. Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end. J Virol. 1975 Oct;16(4):1051–1070. doi: 10.1128/jvi.16.4.1051-1070.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Whalen L. R., Wheeler D. W., Gould D. H., Fiscus S. A., Boggie L. C., Smith R. E. Functional and structural alterations of the nervous system induced by avian retrovirus RAV-7. Microb Pathog. 1988 Jun;4(6):401–416. doi: 10.1016/0882-4010(88)90026-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES